Mahajan Imaging & Labs, a pioneer in integrated diagnostics and advanced medical imaging, has entered a strategic alliance with Fortis La Femme, India’s leading hospital dedicated to women’s and children’s health, to create a new benchmark in...
India is scheduled to overhaul the regulations under the Biological Diversity Act, 2002 with the intention of boosting the ayurvedic medicine
Davaindia, one of India’s largest and fastest-growing retail pharmacy chains, has taken its e-commerce services in Jaipur, and is building the company’s digital presence. This move brings the generics-driven retailer's total online presence to more..
Aurobindo Pharma announced today that its wholly owned subsidiary Apitoria Pharma received a Form 483 with five observations from the US Food and Drug Administration (FDA). The form was received after the agency performed an inspection of its...
Sai Life Sciences, a Contract Research, Development, and Manufacturing Organization (CRDMO) focused on innovation, has announced the successful completion of Phase II of its new Production Block (PB-11) at the company’s primary API manufacturing
Eli Lilly and Company announced positive top-line results in the Phase 3 ATTAIN-2 trial that evaluated, orforglipron, an investigational oral GLP-1 receptor agonist in adults with obesity or overweight and type 2 diabetes. The ATTAIN-2 trial showed
The plan to combine these separately listed businesses under the Dr. Agarwal's Group has been accepted by the boards of directors of Dr. Agarwal's Health Care Limited (AHCL) and Dr. Agarwal's Eye Hospital Limited (AEHL).
Bristol Myers Squibb presented major clinical and real-world results of its cardiovascular line at the European Society of Cardiology (ESC) Congress, which took place between August 29 and September 1, 2025, in Madrid, Spain. New data on Camzyos (mav
The second chapter of Garmin India's strategic partnership with Apollo HealthAxis, a division of Apollo Hospitals, aims to enhance chronic illness management, health monitoring, and general wellbeing across India. The partnership has entered a new
Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries Ltd., has announced the FDA approval and U.S. market availability of the first generic version of Saxenda
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")